
On 3 August 2026, NHS England apologised. The apology confirmed what National Data Guardian Nicola Byrne had identified five days earlier: the Data Protection Impact Assessment (DPIA) for the Federated Data Platform had stated that only NHS staff could access identifiable patient data. That statement was wrong. Palantir staff held access to identifiable patient information within the national data integration environment, an arrangement the DPIA had not disclosed.
This is the fifteenth piece in the Pre-Mortem series. Five questions, applied to the public record, before the outcome is known.
The Bet
NHS England is betting that a £330 million platform built on Palantir’s proprietary Foundry software can serve as the trusted data infrastructure for NHS analytics, and that the governance commitments made publicly about data access are auditable in practice. The bet has been partially called already. The DPIA that underpinned the programme’s public accountability framework described access controls that did not match operational reality. NHS England acknowledged the error and corrected it. The bet that now matters: that the February 2027 break clause decision, whether to extend or exit, can be made on the basis of accurate information.
The Assumption
The single belief the whole framework rests on: that NHS England can demonstrate meaningful oversight and control of a platform whose codebase NHS analysts cannot read or edit. Palantir owns the Foundry software. NHS analysts work within the platform but cannot examine or modify the code that shapes its outputs. The National Data Guardian (NDG) criticism was triggered by the gap between what was publicly asserted about data access and what was operationally true. If the accountability assertion in the DPIA did not survive scrutiny, the assumption that NHS England can verify what Palantir staff do with patient data inside a proprietary system deserves the same examination.
The Sequence
November 2023. Palantir wins the £330 million FDP contract.
April 2026. Parliamentary debate on the FDP. NHS England officials warned staff internally not to criticise the platform’s performance.
12 May 2026. NHS England confirms Palantir staff have administrative access to identifiable patient data in the national data integration environment, contradicting earlier assurances.
June 2026. The government announces a formal review of the Palantir contract, following a Science, Innovation and Technology Committee report that branded the company “an unacceptable point of weakness” in UK public sector infrastructure.
9 July 2026. The Health and Social Care Committee writes to the Health Innovation Minister recommending the exercise of the February 2027 break clause, citing “serious mistrust” among the public towards Palantir.
29 July 2026. National Data Guardian Nicola Byrne formally criticises NHS England for inaccurate DPIA disclosure.
3 August 2026. NHS England apologises and confirms the DPIA error.
The Pager
The National Data Guardian used her statutory function and the result was a public apology from NHS England. The named individual who authorised the submission of a DPIA that did not accurately describe Palantir staff access has not been identified publicly. Jules Hunt, interim Director General for Technology, Digital and Data, holds the relevant executive function. The chief digital and information officer role has not had a permanent holder since at least early 2025; the most recent interim departed in April 2026, before the DPIA error became public. The programme sits with interim leadership in the window immediately before the most consequential procurement decision of its lifespan.
The Proof
February 2027 is the break clause decision point. The Department of Health and Social Care must actively trigger the first extension; if it does not, the contract lapses in spring 2027. The Health and Social Care Committee’s recommendation is on the public record. The government has not yet responded. The outcome measure is binary and specific: the break clause is exercised or it is not. Whether the platform’s actual adoption record across NHS trusts factors into that decision is the proof measure.
Verdict
If the government exercises the February 2027 break clause, it becomes the first time a cross-party parliamentary committee recommendation, a National Data Guardian rebuke, and a public apology from the contracting body have together produced a procurement exit in NHS technology history. That would be a significant accountability signal for every future public sector AI contract. If the contract is extended, the question shifts to what changed in the governance architecture to justify continuation, and whether the interim executives carrying the programme can demonstrate what that change looks like in operational terms. The break clause is not a threat. It is a proof point with a date.








